13 nominees · 3 ballot items.
Elect 13 directors; advisory (nonbinding) vote to approve named executive officers’ compensation (Say-on-Pay); ratify KPMG LLP as independent registered public accounting firm for 2026.
Elect a Board of 13 directors to serve until the next annual meeting and until their successors are elected and qualify.
Nonbinding advisory approval (Say-on-Pay) of the compensation disclosed for the Company’s Named Executive Officers.
This management proposal requests a nonbinding advisory vote to approve the Company’s disclosed NEO compensation (Say-on-Pay). Management frames the program as goal-oriented, long-term focused, and aligned with stockholders through substantial performance-based pay (annual bonuses tied to operating metrics and long-term RSUs with performance vesting tied to operating margin versus peers, and special OHA compensation arrangements for OHA executives). The Compensation Committee uses a mix of quantitative (adjusted operating margin, relative investment performance, relative organic growth) and qualitative metrics for CEO pay, with a framework that allocated approximately 70% quantitative and 30% qualitative for 2025; the CEO’s incentive is ~50% cash and 50% equity. Management highlights governance practices—independent consultant, recoupment policies, stock ownership guidelines, double-trigger change-in-control vesting—that it argues mitigate excessive risk-taking. The Board recommends FOR and cites strong prior support (~89% in 2025). Key context: the firm completed the OHA acquisition, which creates distinct compensation (carried interest, OHA Pool) for OHA employees and potential related-party considerations for Glenn August, an NEO and director. Opponents could point to high absolute CEO pay, and the use of discretion in awards; supporters note alignment via long-term equity and performance metrics and strong recent stockholder approval. The proposal’s outcome is advisory but will inform future pay design and the Compensation Committee’s decisions.
Ratify KPMG LLP as the Company’s independent registered public accounting firm for 2026.
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | STATE STREET CORP | 6.66% | 14,272,295 | $1.3B |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 6.61% | 14,161,471 | $1.3B |
| 3 | BlackRock, Inc. | 5.72% | 12,264,861 | $1.1B |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 4.75% | 10,169,583 | $917M |
| 5 | GOLDMAN SACHS GROUP INC | 3.42% | 7,325,534 | $660M |
| 6 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.09% | 6,614,704 | $596M |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.61% | 5,584,636 | $502M |
| 8 | BlackRock, Inc. | 2.08% | 4,453,263 | $401M |
| 9 | Invesco Ltd. | 1.73% | 3,716,624 | $335M |
| 10 | FIRST TRUST ADVISORS LP | 1.72% | 3,694,171 | $333M |
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.